Technology
Navigating EV Manufacturing Quality with Karthick Ravichandran
Karthick Ravichandran’s core argument is one the automotive industry is learning under pressure: quality planning ...
Manishkumar Patel, a Manufacturing Engineer and Six Sigma Green Belter, is advancing automation in high-mix, low-volume pharmaceutical and medical device manufacturing. With nearly a decade of experience, he integrates modular robotics to enhance precision, efficiency, and compliance under FDA standards. His work demonstrates how adaptable robotic systems and lean principles can transform regulated production environments into agile, cost-effective, and future-ready operations.
As pharmaceutical and medical device manufacturing shifts toward smaller, more customized product batches, traditional automation struggles to keep pace. This has created a critical need for flexible solutions that can handle high-mix, low-volume production without compromising the industry’s stringent quality and compliance standards.
Manishkumar Patel, a Manufacturing Engineer with a Master’s degree in Mechanical Engineering and a Six Sigma Green Belter, is focused on this transition. With nearly a decade of experience, his work on integrating modular robotics provides key insights into how robots are reshaping production floors. Patel’s approach demonstrates how to improve efficiency while adhering to strict regulatory protocols.
The drive to integrate robotics into highly regulated fields stems from a dual focus on performance and patient safety. For many engineers, the initial interest is rooted in the technical capabilities of automated systems.
Patel states, “I’ve always been fascinated by robotics and automation—especially how robots can perform tasks with precision, efficiency, and minimal human intervention.”
This interest quickly finds practical application in the medical device sector, where consistency is paramount. Automation offers a pathway to standardize processes essential for compliance and product reliability.
Patel adds, “In the medical device field, I quickly saw how automation could go beyond just productivity gains: it plays a direct role in improving quality, reducing downtime, and ensuring consistent results in the assembly of at-home test kits.” This focus on quality is critical, as automated systems lead to more consistent handling and a notable reduction in rejects. The financial benefits are also clear, with robots often achieving a return on investment within six to twelve months.
High-mix production environments present a significant challenge for traditional, rigid automation. The solution lies in creating inherently adaptable systems.
“I implemented modular robot cells by designing them to be flexible and reconfigurable, so that the same robotic platform could handle multiple product variations with minimal changeover time,” Patel explains. This involves using interchangeable tooling and adaptable software logic.
Standardization is the key to managing this flexibility without introducing new risks. “By standardizing the robot cell design and building modularity into both hardware and software, we were able to overcome these challenges, reduce setup times, and maintain consistent quality across diverse product lines,” he says.
This strategy is mirrored in broader industry trends, where Robotics-as-a-Service (RaaS) models are making automation more accessible for smaller manufacturers. Similar modular principles are being used to develop GMP-compliant, fully closed robotic systems for aseptic processing.
Integrating robots successfully depends heavily on the human workforce that interacts with them. Effective training is essential for both safety and efficiency. Patel notes, “We developed a structured upskilling program using a detailed training matrix that listed all common robot and machine faults along with their corresponding fault codes, root causes, and step-by-step resolution procedures.”
This hands-on approach builds confidence and competence, turning operators into frontline problem-solvers. “This progressive approach ensured consistent knowledge transfer, increased operator confidence, and reduced machine downtime due to faster, more effective fault resolution and tooling swaps,” he adds.
As human-robot collaboration becomes more common, understanding human factors like trust and cognitive workload is crucial. Modern systems aid this by simplifying programming, with some user-friendly interfaces allowing operators to program weld points in hours, even without previous robotics experience.
The COVID-19 pandemic served as a global stress test for manufacturing agility, demanding rapid scaling and adaptation. During this period, Patel was tasked with a critical project.
“I was designated as the lead engineer responsible for the vial filler machine—a critical component of the production process, as it produces one of the essential elements included in the test kit,” he recounts.
The challenge was immense, requiring the commissioning of entirely new equipment under intense time pressure. “The vial fillers were newly developed equipment, with no existing operating procedures, risk assessments, or supporting documentation. Despite the challenges, I completed this work in a record time of two months,” Patel says.
This experience highlights the value of agile manufacturing paradigms, such as the Portable, Continuous, Miniature, and Modular (PCMM) model pioneered by Pfizer. These approaches, however, also introduce new regulatory questions, as current US regulations define a manufacturing establishment by a single physical location.
In FDA-regulated industries, efficiency gains cannot come at the expense of compliance. Integrating robotic systems requires a validation strategy that is built in from the start.
“I make sure compliance is built into the design from the start by focusing on repeatability, traceability, and data integrity when updating robotic systems or PLC programs,” Patel states.
This proactive approach involves deep collaboration with quality and validation teams to ensure every requirement is met. He adds, “For validation, I work closely with validation engineers—supporting them with technical input and making adjustments so the system can meet IQ/OQ/PQ requirements.”
This process aligns with the FDA’s three-stage process validation lifecycle. The final step, Process Performance Qualification (PPQ), is a formal protocol that confirms the process can reproducibly manufacture a quality product, outlining everything from sampling plans to acceptance criteria.
The business case for automation ultimately rests on its return on investment, measured in both productivity and cost reduction. Patel describes a project where he optimized an automated vial filler machine.
“I identified an opportunity to increase the output to 80 vials per minute from 70 vials per minute by analyzing the machine’s performance and pinpointing a bottleneck—specifically, a station that was operating slower than the rest due to hardcoded timing constraints in the PLC program,” he explains.
By carefully re-engineering the system’s logic, he achieved significant gains without compromising reliability. “The resulting efficiency led to an annual labor savings equivalent to nearly two months of production time,” Patel notes.
Automation is most effective when paired with a continuous improvement mindset. For Patel, lean manufacturing principles provide the framework for designing efficient and sustainable systems.
“Lean manufacturing has been a key framework in how I approach automation and process improvements. By focusing on identifying and eliminating waste—whether it’s downtime, excess motion, or unnecessary steps—I’ve been able to design automation solutions that are not just efficient, but also streamlined and sustainable,” he says.
This philosophy ensures that technology serves a clear purpose: creating value. Patel continues, “Lean methodology has helped me prioritize value-added activities, ensure that automation efforts directly improve productivity and quality, and create processes that are easier to maintain in the long run.”
Specialized software, like an MES with dynamic scheduling technology, can deliver significant reductions in changeover times. However, it’s worth noting that robots used for high-precision tasks can initially cause a temporary decrease in production rate compared to human teams, reinforcing the need for careful process optimization.
Looking ahead, the capabilities of collaborative robots in regulated industries are set to expand significantly, driven largely by artificial intelligence. “Over the next five years, I see collaborative robotics becoming increasingly transformative,” Patel predicts. “Advancements in AI-driven vision systems and machine learning will allow robots to adapt in real time, improving accuracy in inspection, assembly, and quality control tasks.”
These technologies will also simplify compliance, a critical factor for adoption in the pharmaceutical and medical device sectors. “Improvements in safety and compliance features, such as built-in data tracking and validation capabilities, will make it easier to align automation with FDA requirements for process integrity and traceability,” he concludes. Already, AI-enhanced robots are achieving 92.3% accuracy in quality control tasks, and AI-powered systems are enabling predictive maintenance to minimize downtime.
The integration of modular robotics into high-mix manufacturing is more than a technological upgrade; it is a strategic response to the evolving demands of the healthcare market. Through a combination of flexible design, diligent validation, and workforce development, companies can build more resilient and adaptive production systems capable of meeting the challenges of tomorrow.
